Strategic market research
Research covers late-stage oncology, rare and life-limiting diseases, targeted medicine, and precision medicine.
Source: LinkedIn company description · Retrieved October 13, 2026
Genactis provides strategic market research for pharmaceutical and biotechnology sectors.
Its research focuses on late-stage oncology, rare and life-limiting diseases, targeted medicine, and precision medicine. The company says it has worked for over 20 years to identify insights for clients, supporting strategy creation for healthcare brands.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
Research covers late-stage oncology, rare and life-limiting diseases, targeted medicine, and precision medicine.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated August 31, 2026, September 4, 2026, September 6, 2026, September 8, 2026, September 10, 2026, September 11, 2026, September 12, 2026, September 14, 2026, September 18, 2026, September 19, 2026, September 20, 2026, September 26, 2026, September 27, 2026, September 28, 2026, October 7, 2026, October 8, 2026 and October 9, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.